Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial

Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial

Summary: Despite the similar clinical outcomes after renin-angiotensin system (RAS) inhibitor (RASi) continuation or withdrawal in COVID-19, the effects on angiotensin-converting enzyme 2 (ACE2) and RAS metabolites remain unclear. In a substudy of the randomized controlled Austrian Corona Virus Adap...

Full description

Bibliographic Details
Main Authors:	Vincent Rathkolb, Marianna T. Traugott, Andreas Heinzel, Marko Poglitsch, Judith Aberle, Farsad Eskandary, Agnes Abrahamowicz, Martin Mueller, Petra Knollmueller, Tarik Shoumariyeh, Jasmin Stuflesser, Ivan Seeber, Georg Gibas, Hannah Mayfurth, Viktoria Tinhof, Lukas Schmoelz, Markus Zeitlinger, Christian Schoergenhofer, Bernd Jilma, Bernd Genser, Wolfgang Hoepler, Sara Omid, Mario Karolyi, Christoph Wenisch, Rainer Oberbauer, Alexander Zoufaly, Manfred Hecking, Roman Reindl-Schwaighofer
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	iScience
Subjects:	Virology Human metabolism
Online Access:	http://www.sciencedirect.com/science/article/pii/S258900422302223X

Similar Items

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
by: M. Karolyi, et al.
Published: (2022-07-01)

The systemic renin-angiotensin system in COVID-19
by: Roman Reindl-Schwaighofer, et al.
Published: (2022-11-01)

Experiences and challenges faced by patients with COVID-19 who were hospitalised and participated in a randomised controlled trial: a qualitative study
by: Allison Tong, et al.
Published: (2022-10-01)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
by: Mario Karolyi, et al.
Published: (2021-07-01)

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19
by: Tamara Seitz, et al.
Published: (2022-06-01)

The Role of Bacterial and Fungal Superinfection in Critical COVID-19
by: Tamara Seitz, et al.
Published: (2022-12-01)

Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19—A Prospective Observational Longitudinal Study
by: Anita Pirabe, et al.
Published: (2021-11-01)

Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers
by: Anita Pirabe, et al.
Published: (2023-03-01)

Efficacy of Sotrovimab (SOT), Molnupiravir (MOL), and Nirmatrelvir/Ritponavir (N/R) and Tolerability of Molnupiravir in Outpatients at High Risk for Severe COVID-19
by: Victoria Kauer, et al.
Published: (2023-05-01)

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
by: Florina Regele, et al.
Published: (2022-06-01)

Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial
by: Georg Gelbenegger, et al.
Published: (2022-04-01)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
by: Farsad Eskandary, et al.
Published: (2019-01-01)

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5
by: Huriye Ercan, et al.
Published: (2021-11-01)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
by: Marianne Graninger, et al.
Published: (2022-05-01)

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
by: Katharina Dörr, et al.
Published: (2022-04-01)

Drug–Drug Interactions in Patients with Acute Respiratory Distress Syndrome
by: Thorsten Bischof, et al.
Published: (2024-02-01)

Low PCSK-9 levels Are Associated with Favorable Neurologic Function after Resuscitation from out of Hospital Cardiac Arrest
by: Anne Merrelaar, et al.
Published: (2020-08-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
by: Georg Gelbenegger, et al.
Published: (2019-11-01)

A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
by: Cristina Groza, et al.
Published: (2023-05-01)

Population-based incidence of all-cause anaphylaxis and its development over time: a systematic review and meta-analysis
by: Vanessa Pühringer, et al.
Published: (2023-12-01)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
by: Nina Buchtele, et al.
Published: (2018-04-01)

Whipple’s disease diagnosed in a patient with suspected sarcoidosis
by: David Totschnig, et al.
Published: (2021-05-01)

Vaccine against toxic shock syndrome in a first-in-man clinical trial
by: Andreas Roetzer, et al.
Published: (2017-02-01)

Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
by: Marlies Antlanger, et al.
Published: (2017-04-01)

Multi-phasic life-threatening anaphylaxis refractory to epinephrine managed by extracorporeal membrane oxygenation (ECMO): A case report
by: Juergen Grafeneder, et al.
Published: (2022-07-01)

Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5.
by: Roman Reindl-Schwaighofer, et al.
Published: (2017-01-01)

Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
by: Georg Gelbenegger, et al.
Published: (2021-08-01)

Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype
by: Waltraud C. Schrottmaier, et al.
Published: (2021-12-01)

The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
by: Lukas Hartl, et al.
Published: (2023-01-01)

Successful treatment of intubation-induced severe neurogenic post-extubation dysphagia using pharyngeal electrical stimulation in a COVID-19 survivor: a case report
by: Marianna Traugott, et al.
Published: (2021-03-01)

Symbolic vs. Bounded Synthesis for Petri Games
by: Bernd Finkbeiner, et al.
Published: (2017-11-01)

Hyperkalemia: A persisting risk. A case report and update on current management
by: Sebastian Schnaubelt, et al.
Published: (2020-09-01)

Author Correction: Admission C-reactive protein concentrations are associated with unfavourable neurological outcome after out-of-hospital cardiac arrest
by: Christoph Schriefl, et al.
Published: (2021-09-01)

Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
by: Stephan Nopp, et al.
Published: (2020-10-01)

Does visceral osteopathic treatment accelerate meconium passage in very low birth weight infants?- A prospective randomized controlled trial.
by: Nadja Haiden, et al.
Published: (2015-01-01)

Correction: Does Visceral Osteopathic Treatment Accelerate Meconium Passage in Very Low Birth Weight Infants?- A Prospective Randomized Controlled Trial.
by: Nadja Haiden, et al.
Published: (2017-01-01)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
by: Katharina A. Mayer, et al.
Published: (2022-04-01)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
by: Iris Medits, et al.
Published: (2022-07-01)

Development and validation of a self-regulation scale within the German version of the Early Development Instrument
by: Sabine Georg, et al.
Published: (2023-10-01)

Estimating the potential reduction in future sickness absence from optimizing group-level psychosocial work characteristics: a prospective, multicenter cohort study in German industrial settings
by: Joachim E. Fischer, et al.
Published: (2020-11-01)